Daniela Tomasoni

Dec 10, 2024 | onlinelibrary.wiley.com | Daniela Tomasoni |Surgical Specialties |Enrico Ammirati |Marco Metra

Corresponding Author Daniela Tomasoni Cardiology, ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy Corresponding author. Cardiology, ASST Spedali Civili di Brescia, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Piazzale Spedali Civili 1, 25123 Brescia, Italy.

Jan 23, 2024 | onlinelibrary.wiley.com | Daniela Tomasoni |Surgical Specialties |Marianna Adamo |Marco Metra

INTRODUCTION December 2023 at a glance: Focus on medical therapy in chronic and acute heart failure Daniela Tomasoni, Daniela Tomasoni Cardiology and Cardiac Catheterization Laboratory, Cardio-Thoracic Department, Civil Hospitals; Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy Search for more papers by this authorMarianna Adamo, Marianna Adamo Cardiology and Cardiac Catheterization Laboratory, Cardio-Thoracic...

Jan 18, 2024 | onlinelibrary.wiley.com | Daniela Tomasoni |Spedali Civili |Surgical Specialties |Antonio Cannata

Corresponding Author Daniela Tomasoni Cardiology, ASST Spedali Civili and Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy Correspondence Daniela Tomasoni, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, Spedali Civili di Brescia, University of Brescia, Brescia, Italy. Email: [email protected] for more papers by this author

Nov 7, 2023 | onlinelibrary.wiley.com | Daniela Tomasoni |Spedali Civili |Surgical Specialties

Introduction Guideline-directed medical therapy (GDMT) consisting of angiotensin-converting enzyme inhibitors (ACEi), angiotensin receptor blockers (ARB), beta-blockers, mineralocorticoid receptor antagonists (MRA) and, more recently, angiotensin receptor–neprilysin inhibitors (ARNI) and sodium–glucose cotransporter 2 (SGLT2) inhibitors, has consistently improved the prognosis of patients with heart failure (HF) and reduced ejection fraction (HFrEF).1, 2 However, many patients continue to...

Aug 29, 2023 | onlinelibrary.wiley.com | Daniela Tomasoni |Surgical Specialties |Marianna Adamo |Marco Metra

Daniela Tomasoni Cardiology and Cardiac Catheterization Laboratory, Cardio-Thoracic Department, Civil Hospitals; Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, ItalySearch for more papers by this author